Boston Common Asset Management, LLC Astrazeneca PLC Transaction History
Boston Common Asset Management, LLC
- $1.7 Billion
- Q4 2024
A detailed history of Boston Common Asset Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Boston Common Asset Management, LLC holds 55,110 shares of AZN stock, worth $3.67 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
55,110
Previous 62,965
12.48%
Holding current value
$3.67 Million
Previous $4.91 Million
26.42%
% of portfolio
0.21%
Previous 0.13%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,349Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.19 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.8 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.48 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.45 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.27 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $206B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...